Literature DB >> 16613574

Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria.

Saeed Emami1, Abbas Shafiee, Alireza Foroumadi.   

Abstract

A major recent focus of quinolone antibacterials has been the development of agents with enhanced activity against Gram-positive bacteria. The extensive research efforts have enabled a better definition of the structural features of quinolones that offer the best combination of clinical efficacy and reduced resistance selection in Gram-positive bacteria. This review considers the structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria, while trying to position them in the context of recent and possible future advances based on an understanding of their chemical structure and how these impact on target specificity, avoidance of efflux and prevention of emergence of quinolone-resistant mutants in Gram-positive bacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16613574     DOI: 10.2174/138955706776361493

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  11 in total

1.  New 7-piperazinylquinolones containing (benzo[d]imidazol-2-yl)methyl moiety as potent antibacterial agents.

Authors:  Hojat-Allah Arab; Mohammad Ali Faramarzi; Nasrin Samadi; Hamid Irannejad; Alireza Foroumadi; Saeed Emami
Journal:  Mol Divers       Date:  2018-06-07       Impact factor: 2.943

2.  Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.

Authors:  Gunther Kern; Tiffany Palmer; David E Ehmann; Adam B Shapiro; Beth Andrews; Gregory S Basarab; Peter Doig; Jun Fan; Ning Gao; Scott D Mills; John Mueller; Shubha Sriram; Jason Thresher; Grant K Walkup
Journal:  J Biol Chem       Date:  2015-07-06       Impact factor: 5.157

3.  Erythrocyte-mediated delivery of bioorthogonal nanozymes for selective targeting of bacterial infections.

Authors:  Akash Gupta; Riddha Das; Jessa Marie Makabenta; Aarohi Gupta; Xianzhi Zhang; Taewon Jeon; Rui Huang; Yuanchang Liu; Sanjana Gopalakrishnan; Roberto-Cao Milán; Vincent M Rotello
Journal:  Mater Horiz       Date:  2021-11-29       Impact factor: 13.266

Review 4.  Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies.

Authors:  Xi Wang; Yuanxun Wang; Xuemin Li; Zhenyang Yu; Chun Song; Yunfei Du
Journal:  RSC Med Chem       Date:  2021-08-10

Review 5.  Microbial transformations of antimicrobial quinolones and related drugs.

Authors:  Igor A Parshikov; John B Sutherland
Journal:  J Ind Microbiol Biotechnol       Date:  2012-09-25       Impact factor: 3.346

6.  Ethyl 4-[2-(3,5-dimethyl-4-oxo-2,6-diphenyl-piperidin-1-yl)-2-oxoeth-yl]piperazine-1-carboxyl-ate.

Authors:  Mannangatty Rani; Rajamanickam Ramachandran; Senthamaraikannan Kabilan; Yeon Tae Jeong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-02-02

7.  Ethyl 4-(phenyl-sulfon-yl)piperazine-1-carboxyl-ate.

Authors:  Mohammad T M Al-Dajani; Hassan H Adballah; Nornisah Mohamed; Madhukar Hemamalini; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-27

8.  Synthesis and In-vitro Antibacterial Activities of Acetylanthracene and Acetylphenanthrene Derivatives of Some Fluoroquinolones.

Authors:  Fazel Shamsa; Alireza Foroumadi; Hashim Shamsa; Nasrin Samadi; Mohammad Ali Faramarzi; Abbas Shafiee
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

9.  Synthesis and antibacterial activity of novel levofloxacin derivatives containing a substituted thienylethyl moiety.

Authors:  Negar Mohammadhosseini; Zahra Alipanahi; Eskandar Alipour; Saeed Emami; Mohammad Ali Faramarzi; Nasrin Samadi; Nika Khoshnevis; Abbass Shafiee; Alireza Foroumadi
Journal:  Daru       Date:  2012-08-30       Impact factor: 3.117

10.  Synthesis and Study of Some New Quinolone Derivatives Containing a 3-acetyl Coumarin for Their Antibacterial and Antifungal Activities.

Authors:  Edris Valadbeigi; Shahram Ghodsi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.